In IBD, where overactive NK or CD8+ T cells damage gut epithelium, activating inhibitory KIRs (e.g., KIR2DL1, KIR3DL1) could restore balance [399]. This evidence concerns the gene KIR2DL1 and inflammatory bowel disease.